Atlas Trials

Oral Liquid 13-cis-retinoic Acid (13-CRA)

Clinical trial NCT03291080 · COMPLETED

Trial details

NCT number
NCT03291080
Sponsor
Nova Laboratories Limited
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2018-04-17
Primary completion
2019-09-12
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.